Q3 2024 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2024-11-14 · accession 0001104659-24-118260
$163.5M
Reported value
6
Positions
2024-09-30
Period end
The Brief · Data Collective IV GP, LLC · Q3 2024
AI · grounded in 13F
Data Collective IV GP, LLC reported no changes to its 13F holdings for 2024-09-30 relative to 2024-06-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02156V109 | OKLO | Oklo Inc. | $56.0M | 34.3% | 6,920,804 | Common | SOLE |
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $39.2M | 24.0% | 9,681,281 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $39.2M | 24.0% | 5,941,120 | Common | SOLE |
| 773122106 | — | Rocket Lab USA, Inc. | $28.5M | 17.4% | 2,929,350 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $570,991 | 0.35% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $44,718 | 0.03% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.